STOCK TITAN

Align Technology Inc Form 4 Filings

ALGN NASDAQ

Every Form 4 that Align Technology Inc (ALGN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ALGN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALGN filings page.

Rhea-AI Summary

ALIGN TECHNOLOGY INC (symbol: ALGN) is the issuer of record for a Form 4 filing submitted to the SEC.

Rhea-AI Summary

ALIGN TECHNOLOGY INC director Britt J. Vitalone reported routine equity compensation activity. On May 20, 2026, 100% of previously granted restricted stock units vested, and 1,443 shares of common stock were delivered, leaving the same number of shares held directly.

On the same date, Vitalone received a new grant of 1,836 restricted stock units, which will vest on the earlier of May 20, 2027 or the next annual stockholder meeting, assuming continued service. The filing shows only acquisitions through RSU vesting and grant, with no open-market purchases or sales.

Rhea-AI Summary

ALIGN TECHNOLOGY INC director Susan E. Siegel reported routine equity compensation activity. She exercised previously granted restricted stock units, receiving 1,745 shares of common stock, bringing her direct holdings to 10,723 shares after the transactions.

She was also granted 1,836 new restricted stock units tied to common stock. These RSUs will fully vest on the earlier of May 20, 2027 or the date of the next annual meeting of stockholders, with shares delivered on that vesting date assuming her continued service.

Rhea-AI Summary

Saia Andrea Lynn reported acquisition or exercise transactions in this Form 4 filing.

ALIGN TECHNOLOGY INC director Andrea Lynn Saia reported equity compensation activity involving company stock. On May 20, 2026, 1,745 restricted stock units (RSUs) granted on May 21, 2025 fully vested and were settled in shares of common stock delivered to her. Following this vesting, she directly held 17,318 shares of common stock.

On the same date, she received a new grant of 1,836 RSUs, each representing one share of common stock. According to the terms, 100% of these RSUs will vest on the earlier of May 20, 2027 or the next annual meeting of stockholders, assuming she continues to serve through that date. After this grant, she directly held 1,836 RSUs in addition to her common shares.

Rhea-AI Summary

ALIGN TECHNOLOGY INC director Poul Mojdeh reported routine equity compensation activity. He exercised derivative securities covering 1,745 shares of Common Stock, bringing his direct Common Stock holdings to 3,553 shares. He also received a grant of 1,836 Restricted Stock Units, which are scheduled to vest on the earlier of May 20, 2027 or the next annual stockholder meeting, subject to continued service.

Rhea-AI Summary

Myong Anne reported acquisition or exercise transactions in this Form 4 filing.

ALIGN TECHNOLOGY INC director Anne Myong reported routine equity compensation activity. On May 20, 2026, 1,745 Restricted Stock Units (RSUs) granted on May 21, 2025 fully vested and were settled in Common Stock, increasing her direct holdings to 9,830 shares. She also received a new grant of 1,836 RSUs that will vest on the earlier of May 20, 2027 or the next annual stockholder meeting, assuming continued service.

Rhea-AI Summary

ALIGN TECHNOLOGY INC director C. Raymond Larkin Jr reported routine equity compensation activity. On May 20, 2026 he exercised 2,326 restricted stock units into 2,326 shares of common stock, bringing his direct common stock holdings to 27,454 shares following the transaction.

He also received a new grant of 2,448 restricted stock units tied to an equal number of common shares. According to the award terms, 100% of these RSUs will vest on the earlier of May 20, 2027 or the date of the next annual meeting of stockholders, subject to his continued service.

Rhea-AI Summary

Dallas Kevin J reported acquisition or exercise transactions in this Form 4 filing.

Align Technology director Kevin J. Dallas reported routine equity compensation activity. On May 20, 2026, 1,745 restricted stock units granted on May 21, 2025 fully vested and were settled in shares of common stock delivered to him. The same day, he received a new award of 1,836 restricted stock units that will vest on the earlier of May 20, 2027 or the date of the next annual meeting of stockholders, assuming continued service. Following these transactions, Dallas directly holds 16,168 shares of Align Technology common stock, and the new RSUs represent additional potential future shares upon vesting.

Rhea-AI Summary

Align Technology director Joseph Lacob reported compensation-related equity activity. On May 20, 2026, 1,745 Restricted Stock Units (RSUs) granted on May 21, 2025 fully vested and were exercised into the same number of shares of common stock, which are held indirectly through a trust.

On the same date, he received a new grant of 1,836 RSUs, each representing one share of common stock upon future vesting. These RSUs will vest on the earlier of May 20, 2027 or the date of the next annual meeting of stockholders, assuming his continued service. Following these transactions, indirect trust holdings stood at 135,916 shares, and 1,836 RSUs remained outstanding directly.

Rhea-AI Summary

Conroy Kevin T reported acquisition or exercise transactions in this Form 4 filing.

ALIGN TECHNOLOGY INC director Kevin T. Conroy reported routine equity compensation changes. On May 20, 2026, 1,745 restricted stock units granted on May 21, 2025 fully vested and were settled in 1,745 shares of common stock, bringing his direct holdings to 3,553 shares.

On the same date, he received a new grant of 1,836 restricted stock units. These RSUs will vest on the earlier of May 20, 2027 or the next annual stockholder meeting, subject to his continued service, and are then deliverable in an equal number of common shares.

Rhea-AI Summary

ALIGN TECHNOLOGY INC director George J. Morrow reported a routine equity compensation event. On May 20, 2026, 1,745 Restricted Stock Units (RSUs) granted on May 21, 2025 fully vested and were converted into an equal number of shares of common stock delivered to him.

Following this RSU vesting, he directly holds 5,036 shares of Align Technology common stock. In addition, 3,273 shares are held indirectly through a family trust. The filing shows no share sales or tax-withholding dispositions, and no remaining derivative position from this RSU grant.

Rhea-AI Summary

ALIGN TECHNOLOGY INC EVP and Chief Financial Officer John Morici reported multiple equity transactions involving restricted stock units, market stock units, and common stock. On February 20, 2026, he received a grant of 8,423 restricted stock units, which vest in four equal annual installments starting February 20, 2027.

He was also granted 17,102 market stock units, representing the target number of shares that may be issued; if performance exceeds target, up to 250% of this target may vest at the end of the three-year performance period. Several previously granted restricted stock units and a market stock unit vested and were converted into common shares through exercises coded as derivative conversions.

Following these transactions, Morici directly owned 13,536 shares of common stock, with 2,549 shares of common stock withheld at a price of $190.02 per share to cover tax obligations associated with the equity vesting.

Rhea-AI Summary

ALIGN TECHNOLOGY executive Stuart A. Hockridge, EVP Global HR, reported multiple equity award vestings and related share movements. On February 20, 2026, several restricted stock unit and market stock unit grants vested, and shares were delivered following earlier grants made between 2022 and 2025.

These vestings resulted in the acquisition of 4,310 shares of common stock through derivative exercises or conversions, bringing direct common stock holdings to 16,102 shares before tax withholding. In a separate transaction coded F, 1,210 shares of common stock at $190.02 per share were disposed of to satisfy tax obligations, leaving 14,892 shares directly owned.

Rhea-AI Summary

ALIGN TECHNOLOGY INC executive Julie Ann Coletti reported multiple equity transactions involving company stock and stock units. On February 20, 2026, she received a grant of 5,493 Restricted Stock Units and 11,153 Market Stock Units, both at a price of $0.00 per unit. The filing notes that the market stock unit amount reflects the target number of shares, and that up to 250% of this target may vest depending on performance.

The report also shows several exercises of previously granted restricted stock units and market stock units on the same date, resulting in the acquisition of 5,864 shares of common stock through derivative exercises. In connection with these equity events, 1,718 shares of common stock were disposed of at $190.02 per share to satisfy tax obligations through share withholding, leaving Coletti with 11,445 shares of common stock held directly after these transactions.

Rhea-AI Summary

ALIGN TECHNOLOGY INC President and CEO Joseph M. Hogan reported multiple equity transactions dated February 20, 2026. He received a grant of 19,144 Restricted Stock Units and 44,670 Market Stock Units, both at a stated price of $0.00 per unit. Several prior RSU and market stock unit awards vested and were exercised, resulting in the acquisition of 40,248 shares of common stock. To satisfy tax obligations, 16,107 common shares were withheld at $190.02 per share, leaving 209,270 common shares held directly. Additional common shares are held indirectly through the Hogan 2025 GRAT and by his spouse, as described in the footnotes.

Rhea-AI Summary

Align Technology executive vice president and chief financial officer John Morici reported an open-market sale of 7,969 shares of common stock on February 18, 2026 at an average price of $189.3143 per share. After these transactions, he directly owns 8,237 shares, which include 183 shares acquired on January 30, 2026 under the company’s employee stock purchase plan. The shares were sold in multiple trades at prices ranging from $189.050 to $189.65.